Related Experiment Video
Updated: Oct 8, 2026

Simultaneous Laryngopharyngeal and Conventional Esophageal pH Monitoring
Published on: December 14, 2020
[The effect of gastro-esophageal reflux therapy on respiratory diseases in children]
Y Levin1, A Mandelberg, A Gornstein
1Sackler Faculty of Medicine, Tel-Aviv University.
Insights
Anti-reflux therapy significantly improved Hyper Reactive Airway Disease (HRAD) in children, reducing medication needs. However, it showed no significant impact on apnea severity, suggesting reflux management is key for HRAD but not apnea.
Area of Science:
- Pediatric Pulmonology
- Gastroenterology
- Sleep Medicine
Background:
- Gastroesophageal reflux is implicated in pediatric respiratory conditions.
- Hyper Reactive Airway Disease (HRAD) and apnea are common in children.
- The role of reflux in these conditions requires further investigation.
Purpose of the Study:
- To evaluate the efficacy of anti-reflux therapy in children with HRAD and apnea.
- To determine if reflux management impacts respiratory status and medication requirements.
Main Methods:
- 107 children (78 with HRAD, 29 with apnea) underwent pH monitoring.
- Pathological reflux was identified using Boix-Ochoa and Reflux Index (RI) scores.
- Patients with reflux received anti-reflux treatment; respiratory status was assessed before and after.
Main Results:
- In HRAD patients with reflux, anti-reflux treatment significantly improved scores (p < 0.0001) and reduced corticosteroid/bronchodilator use (p < 0.01, p = 0.042).
- HRAD patients without reflux showed no significant improvement.
- All apnea patients improved, irrespective of reflux status or treatment.
Conclusions:
- Anti-reflux therapy may offer an additive benefit for Hyper Reactive Airway Disease severity.
- pH monitoring is recommended for severe HRAD patients to identify and treat reflux.
- Reflux does not appear to significantly influence apnea severity or treatment outcomes.
Unlabelled:
In order to examine the effect of reflux therapy on Hyper Reactive Airway Disease (HRAD) and apnea severity, 107 children, 78 with HRAD and 29 with apnea, underwent pH monitoring in the Pediatric Surgery Unit of Wolfson Hospital and the Dana Children's Hospital during the years 1995-1998. Pathological reflux was defined by means of the Boix-Ochoa and RI (Reflux Index) scores. In patients with positive reflux, anti-reflux treatment was initiated. Prior to and following pH monitoring, the respiratory status of all patients (both with and without reflux) was evaluated by a pediatric pulmonologist employing commonly used scores to determine severity.
Results:
Subject age ranged between one day and 15 years (mean: 15.44 +/- 29 months, median: 6.37 months). In HRAD, following anti-reflex treatment the reflux positive group showed a significant score improvement, from an average of 2.9 +/- 1.1 units to 1.54 +/- 1.2 units (p < 0.0001); a decrease in the number of patients treated with oral corticosteroids (p < 0.01); a close to significant decrease (p = 0.069) in the average dose of inhaled corticosteroids; and a decrease in the number of patients using bronchodilators (p = 0.042). The reflux-negative group, not treated for reflux, displayed no significant improvement, with only a decrease in the severity scores from 2.44 +/- 1.0 to 1.78 +/- 1.2 units (p = 0.14), and no change on any of the other parameters. In apnea, all patients improved, from an average score of 2.34 +/- 0.77 to 0.03 +/- 0.19 units (p < 0.0001), with no significant difference between the reflux positive and the reflux negative groups. In view of these findings, it is postulated that anti-reflux therapy may have an additive effect on HRAD severity, beyond that of spontaneous respiratory improvement. We therefore find it appropriate for every severe HRAD patient (frequent exacerbations or high corticosteroid dose) to undergo pH monitoring in order to treat those with proven reflux. In respect to apnea, we cannot attribute any significance to the existence of reflux or to anti-reflux treatment.
Related Concept Videos
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Gastroesophageal Reflux Disease
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
Esophageal Strictures-I: Introduction
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
Respiratory Syncytial Virus Disease
